Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥2.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥94m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥116m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥120m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥352m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥131m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥119m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥131m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥82m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥340m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥113m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥82m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥113m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥4.4bnat 2022-09-30Cons.Assets
Total assets¥4.6bnat 2022-03-31Cons.Assets
Total assets¥4.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥191m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥659m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥295m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥19m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥66m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥37m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥72m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥66m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥60.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.992022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.752021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥802021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.9%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥48m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-09-30¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥100m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥84m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2021-04-01 → 2021-09-30¥78m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥262m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)静岡県浜松市北区細江町中川7000番地の35
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Quarterly consolidated statement of cash flows (text)CurrentYTDDurationText · Plus
Notes additional information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Major components of selling general and administrative expenses (text)CurrentYTDDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDurationText · Plus
Notes regarding dividend (text)Prior1YTDDurationText · Plus
Notes regarding dividend (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)Prior1YTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass